Managing LDL-C to Reduce Cardiovascular Disease Risk: Defining Best Clinical Practice

I don't want best clinical practice, that is just laziness. I want a protocol. For this objective starting point ; these exact interventions need to occur. Nothing should be left to chance and interpretation. But that is just my non-medical understanding. Prove me wrong and I can change my position.

Registration and Dinner: 6:30-7 p.m.
Symposium: 7-9 p.m., Sunday, Nov. 11
InterContinental Chicago Grand Ballroom, 7th Floor
Sponsor: Voxmedia - Supporter: Amgen

Program Overview: Nonstatin drugs (ezetimibe, PCSK9 inhibitors) further lower LDL-C and further reduce cardiovascular risk when added to statins, while demonstrating safety at low LDL-C levels. 

MORE